These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1885735)
1. Production and characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis. Fulop MJ; Webber T; Manchee RJ; Kelly DC J Clin Microbiol; 1991 Jul; 29(7):1407-12. PubMed ID: 1885735 [TBL] [Abstract][Full Text] [Related]
2. Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis. Bhatti AR; Wong JP; Woods DE Hybridoma; 1993 Apr; 12(2):197-202. PubMed ID: 7686137 [TBL] [Abstract][Full Text] [Related]
4. Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay. Sharma N; Hotta A; Yamamoto Y; Fujita O; Uda A; Morikawa S; Yamada A; Tanabayashi K Clin Vaccine Immunol; 2013 Jan; 20(1):9-16. PubMed ID: 23114700 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. Viljanen MK; Nurmi T; Salminen A J Infect Dis; 1983 Oct; 148(4):715-20. PubMed ID: 6631062 [TBL] [Abstract][Full Text] [Related]
6. Use of a zwitterionic detergent for the restoration of the antibody binding capacity of immunoblotted Francisella tularensis lipopolysaccharide. Fulop MJ; Webber T; Manchee RJ Anal Biochem; 1992 May; 203(1):141-5. PubMed ID: 1524210 [TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide. Roche MI; Lu Z; Hui JH; Sharon J Hybridoma (Larchmt); 2011 Feb; 30(1):19-28. PubMed ID: 21466282 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis. Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to both terminal and internal B-cell epitopes of Francisella tularensis O-polysaccharide produced by patients with tularemia. Lu Z; Perkins HM; Sharon J Clin Vaccine Immunol; 2014 Feb; 21(2):227-33. PubMed ID: 24351753 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. Sandström G; Sjöstedt A; Johansson T; Kuoppa K; Williams JC FEMS Microbiol Immunol; 1992 Oct; 5(4):201-10. PubMed ID: 1419118 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide microarrays for the detection of antibodies. Thirumalapura NR; Morton RJ; Ramachandran A; Malayer JR J Immunol Methods; 2005 Mar; 298(1-2):73-81. PubMed ID: 15847798 [TBL] [Abstract][Full Text] [Related]
20. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis. Hotta A; Uda A; Fujita O; Tanabayashi K; Yamada A Clin Vaccine Immunol; 2007 Jan; 14(1):81-4. PubMed ID: 17121981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]